---
title: "Advance Agrolife Ltd (ADVANCE) — Share Price, Financials & Analysis"
symbol: "ADVANCE"
company: "Advance Agrolife Ltd"
canonical: "https://tapetide.com/stocks/ADVANCE"
isin: "INE1B0W01010"
nse_symbol: "ADVANCE"
bse_code: "544562"
sector: "Chemicals"
industry: "Pesticides & Agrochemicals"
market_cap_cr: 761.98
generated_at: "2026-09-13T18:45:58.614Z"
---

# Advance Agrolife Ltd (ADVANCE)

Canonical page: https://tapetide.com/stocks/ADVANCE

## Company

- **NSE Symbol:** ADVANCE
- **BSE Code:** 544562
- **ISIN:** INE1B0W01010
- **Sector:** Chemicals
- **Industry:** Pesticides & Agrochemicals
- **Macro Sector:** Commodities
- **Stock Type:** EQUITY
- **Listed Since:** 2025-10-08
- **CEO:** Mr. Om Prakash Choudhary
- **Employees:** 269
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** advanceagrolife.com

## About

Advance Agrolife is engaged in the business of manufacturing and distributor of broad spectrum of technical and formulated grade of agrochemicals.(Source : 202503 Annual Report Page No:33)

## Latest Price

- **Price:** ₹117.85
- **Change:** -1.18 (-0.99%)
- **Open:** ₹119.03
- **Day High:** ₹119.03
- **Day Low:** ₹116.62
- **Previous Close:** ₹119.03
- **Volume:** 65560
- **As Of:** 2026-09-11T10:01:41+00:00

## Key Fundamentals

Observed at 2026-09-11T04:47:36.921354Z.

- **Market Cap:** ₹761.98 Cr
- **Classification:** Microcap
- **P/E (reported):** 15.7
- **P/E (TTM):** 13.59
- **EPS (TTM):** ₹8.67
- **Book Value:** ₹48.21
- **Price to Book:** 2.47
- **Dividend Yield:** 0%
- **ROE:** 25.42%
- **ROCE:** 34.87%
- **Debt to Equity:** 0.32
- **Revenue (yearly):** ₹502.9 Cr
- **Net Income:** ₹25.6 Cr
- **EBITDA:** ₹48.2 Cr
- **52-Week High:** ₹154
- **52-Week Low:** ₹84.1
- **RSI (14):** 52.76

## Tapetide Score

- **Score:** 59 / 100
- **Score date:** 2026-09-04
- **Archetype:** Weak and Under Pressure
- **What it means:** Weak financials are the defining feature, and neither the valuation nor the trend reading is strong enough to offset them. Worth reading the risk flags and recent filings closely before anything else.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Falling
- **Percentile:** 84.7 (of 4473 scored stocks)
- **Confidence:** 100%
- **Data coverage:** 100%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 47.95 | 9% |
| growth | 97.91 | 9% |
| momentum | 46.25 | 12% |
| ownership | 82.6 | 24% |
| quality | 49.85 | 22% |
| valuation | 42.3 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Strengths

- Company is expected to give good quarter
- Company has delivered good profit growth of 31.3% CAGR over last 5 years
- Company has a good return on equity (ROE) track record: 3 Years ROE 24.0%

### Weaknesses

- Though the company is reporting repeated profits, it is not paying out dividend
- Working capital days have increased from 42.3 days to 70.9 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | -61.52% | -46.88% | -30.79% |
| ebitda margin growth | 129.22% | 9.1% | — | — |
| net income growth | 200% | 3.64% | 33% | 31% |
| revenue growth | 162.59% | 10% | 17% | 26% |
| roce | 158.86% | -15.08% | — | — |
| roe | 202.28% | -22.64% | — | — |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 132 | 167 | 113 | 90 | 169 | 213 | 133 | 124 | 330 |
| Expenses | 119 | 144 | 107 | 84 | 152 | 187 | 125 | 110 | 295 |
| Operating Profit | 12 | 23 | 6 | 6 | 17 | 26 | 7 | 13 | 35 |
| OPM % | 9 | 14 | 6 | 7 | 10 | 12 | 6 | 11 | 11 |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 2 | 0 |
| Interest | 1 | 1 | 1 | 2 | 2 | 2 | 1 | 2 | 2 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 3 |
| Profit before tax | 10 | 20 | 3 | 2 | 13 | 21 | 4 | 10 | 30 |
| Tax % | 28 | 29 | 17 | 28 | 29 | 25 | 30 | 25 | 25 |
| Net Profit | 7 | 14 | 3 | 1 | 9 | 16 | 3 | 7 | 23 |
| EPS in Rs | 16.04 | 31.6 | 6.18 | 0.32 | 1.99 | 3.53 | 0.47 | 1.16 | 3.51 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 204 | 250 | 395 | 451 | 496 | 636 | 800 |
| Expenses | 188 | 235 | 370 | 412 | 447 | 571 | 718 |
| Operating Profit | 16 | 15 | 25 | 40 | 49 | 65 | 82 |
| OPM % | 8 | 6 | 6 | 9 | 10 | 10 | 10 |
| Other Income | 0 | 2 | 0 | 1 | 1 | 4 | 4 |
| Interest | 2 | 2 | 3 | 4 | 7 | 10 | 8 |
| Depreciation | 2 | 2 | 2 | 3 | 8 | 11 | 11 |
| Profit before tax | 12 | 12 | 20 | 33 | 35 | 48 | 66 |
| Tax % | 27 | 28 | 26 | 26 | 27 | 27 | — |
| Net Profit | 9 | 9 | 15 | 25 | 26 | 35 | 49 |
| EPS in Rs | 20.09 | 19.98 | 33.04 | 54.96 | 5.7 | 5.49 | 8.67 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 4 | 4 | 4 | 4 | 45 | 64 |
| Reserves | 22 | 31 | 46 | 71 | 56 | 246 |
| Borrowings | 16 | 21 | 25 | 45 | 80 | 98 |
| Other Liabilities | 43 | 62 | 104 | 139 | 170 | 217 |
| Total Liabilities | 86 | 119 | 179 | 260 | 351 | 625 |
| Fixed Assets | 16 | 17 | 23 | 40 | 66 | 83 |
| CWIP | 0 | 0 | 0 | 9 | 11 | 22 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 70 | 102 | 157 | 210 | 275 | 520 |
| Total Assets | 86 | 119 | 179 | 260 | 351 | 625 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 8 | 0 | 6 | 15 | 6 | -70 |
| Cash from Investing Activity | -6 | -3 | -8 | -31 | -34 | -108 |
| Cash from Financing Activity | -2 | 4 | 1 | 17 | 28 | 183 |
| Net Cash Flow | 0 | 0 | 0 | 0 | 0 | 5 |
| Free Cash Flow | 2 | -3 | -2 | -15 | -28 | -109 |
| CFO/OP | 50 | 30 | 38 | 55 | 27 | -81 |

### Ratios

| Item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 82 | 96 | 96 | 116 | 120 | 113 |
| Inventory Days | — | 53 | 44 | 49 | 84 | 154 |
| Days Payable | — | 95 | 105 | 129 | 152 | 156 |
| Cash Conversion Cycle | 82 | 54 | 35 | 37 | 52 | 110 |
| Working Capital Days | 32 | 31 | 31 | 30 | 26 | 71 |
| ROCE % | — | 30 | 35 | 38 | 28 | 20 |

## Shareholding Pattern

### Quarterly

| Category | Mar 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- |
| Promoters | 99.84% | 99.84% | 69.89% | 69.89% | 69.89% |
| FIIs | 0% | 0% | 4.43% | 2.58% | 3.82% |
| DIIs | 0% | 0% | 2.04% | 1.92% | 2.08% |
| Government | 0% | 0% | 0.6% | 0% | 0% |
| Public | 0% | 0% | 9.85% | 12.58% | 12.43% |
| Others | 0.16% | 0.16% | 13.2% | 13.03% | 11.78% |
| No. of Shareholders | 12 | 12 | 14925 | 13386 | 13285 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 7 / 2

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 116.92 | Buy |
| EMA (10) | 117.27 | Buy |
| SMA (20) | 117.65 | Buy |
| EMA (20) | 117.7 | Buy |
| SMA (50) | 117.26 | Buy |
| EMA (50) | 116.29 | Buy |
| SMA (100) | 111.53 | Buy |
| EMA (100) | 114.5 | Buy |
| SMA (200) | 114.98 | Buy |
| EMA (200) | 117.26 | Buy |

### Oscillators — summary: **Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 50.44 | Neutral |
| MACD (12,26,9) | -0.27 | Sell |
| Stochastic (14,3,3) | 31.06 | Neutral |
| ADX (14) | 20.72 | Neutral |
| Williams %R (14) | -60.83 | Neutral |
| ATR (14) | 4.92 | High Volatility |
| ROC (12) | -3.86 | Sell |
| Stoch RSI (14) | 55.64 | Neutral |
| UO (7,14,28) | 36.17 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-29 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d31598ad-59f3-4f70-bf56-7d4903547697.pdf) |
| 2026-08-27 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d9662ce6-6e4d-4cab-9aa4-98608bb58588.pdf) |
| 2026-08-26 | [Notice Of The 24Th Annual General Meeting And Annual Report For The Financial Year 2025-26](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9690dea2-a6b1-4751-8d64-d497f0472b6b.pdf) |
| 2026-08-26 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=89ad4422-0d44-4589-abb7-5a84c2eceb68.pdf) |
| 2026-08-26 | [Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations & Disclosure Requirements) Regulations 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1af422b8-9257-4933-8e58-f640e7ab9318.pdf) |
| 2026-08-22 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79df82fb-9b82-47f3-be88-0d529b3a2dc6.pdf) |
| 2026-08-07 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db68e34d-739e-4c4a-9b2c-144a9bea6178.pdf) |
| 2026-08-06 | [Board Meeting Outcome for Outcome Of BM](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=db26e9f3-79a7-4449-b921-bd73bff718e0.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=41a0bd99-6f3e-4db4-94b8-f7b81e93023f.pdf) |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Change in Directorate](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8122f942-38ae-48fa-8fab-7ab8cf17d5dd.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-06 | [Results Of Financials For Q1](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9cf10d54-5a26-4d81-b25a-18e5a438c67c.pdf) |
| 2026-05-08 | [Audited Financial Results For Quarterly And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=94855ff9-2e54-4720-b8b5-959db5dcf587.pdf) |
| 2026-02-07 | [Unaudited Financial Results (Standalone) For The Quarter And Nine Months Ended December 31 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=885413e2-bd1f-48f1-8798-8a781145fdef.pdf) |
| 2025-11-14 | [Unaudited Financial Results (Standalone) For The Quarter And Half Year Ended September 30 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2cec8dbb-f9ba-4fc7-b25f-9e019a185852.pdf) |
| 2025-10-29 | [Unaudited Financial Results](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=97154b4b-257e-4991-a9db-478345e15c83.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-06 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9374aa98-afeb-4708-a040-8a4020610f53.pdf) |
| 2026-05-08 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4baf02dc-c124-42f3-b09c-16005284cb95.pdf) |
| 2026-02-07 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9db3f2e7-d649-4727-b22e-8ba4bd58cc16.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 9 Apr - Certificate As per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 9 Apr - Certificate As per Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2af3dbb5-6fb8-4efa-abb9-988a71dd02e9.pdf) |
| 8h - Advance Agrolife reported Q4 FY26 revenue of ₹1,259.07 million, PAT ₹74.61 million, and plans Unit-4 and Unit-5 expansion. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 8h - Advance Agrolife reported Q4 FY26 revenue of ₹1,259.07 million, PAT ₹74.61 million, and plans Unit-4 and Unit-5 expansion.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/14510283-e996-4f65-9569-81ff8ec60b3b.pdf) |
| 8 May - No deviation in utilization of ₹1,928.42 million IPO proceeds for quarter ended March 31, 2026. | [Statement Of Deviation (S) Or Variation (S) For The Quarter Ended March 31, 2026 8 May - No deviation in utilization of ₹1,928.42 million IPO proceeds for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4d75c246-7ab0-405d-b458-71ef82329034.pdf) |
| 8 May - Investors Presentation for the quarter and Financial year ended March 31, 2026 | [Announcement under Regulation 30 (LODR)-Investor Presentation 8 May - Investors Presentation for the quarter and Financial year ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/4baf02dc-c124-42f3-b09c-16005284cb95.pdf) |
| 8 May - CARE report for quarter ended March 31, 2026 shows IPO proceeds utilization of Rs. 192.84 crore, with nil deviation. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 8 May - CARE report for quarter ended March 31, 2026 shows IPO proceeds utilization of Rs. 192.84 crore, with nil deviation.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/71ec1579-9151-455d-8527-b258c3a05fad.pdf) |
| 8 May - Board approved audited standalone FY26 results on May 8, 2026, with unmodified opinion and auditor reappointments. | [Re-Appointment Of Internal & Cost Auditors 8 May - Board approved audited standalone FY26 results on May 8, 2026, with unmodified opinion and auditor reappointments.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/234e5d12-a5d0-42d0-99f1-8ac91454f7d1.pdf) |
| 8 Feb - Results of the Company for the quarter and nine months ended on December 31,2025 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Feb - Results of the Company for the quarter and nine months ended on December 31,2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8792a8e0-f04a-4e04-a01e-fde67b6fe459.pdf) |
| 6 Mar - Of Participation in 'Bharat Connect Conference: Rising Stars- March 2026' an Investor Conference organised by Arihant Capital Markets Limited | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 6 Mar - Of Participation in 'Bharat Connect Conference: Rising Stars- March 2026' an Investor Conference organised by Arihant Capital Markets Limited](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce76126e-4b8e-41f0-aa43-582923ceb7cf.pdf) |
| 2d - Newspaper Publication for the Audited Financial Results for the Quarter and Year ended March 31, 2026 | [Announcement under Regulation 30 (LODR)-Newspaper Publication 2d - Newspaper Publication for the Audited Financial Results for the Quarter and Year ended March 31, 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/cb60c39d-dec8-4f50-89e0-e62ca15d8751.pdf) |
| 2d - Board meeting on May 8, 2026 to approve audited Q4 and FY2026 results; trading window remains closed. | [Board Meeting Intimation for The Approval Of Audited Financial Results Of The Company For The Quarter And Financial Year Ended 31St March 2026 2d - Board meeting on May 8, 2026 to approve audited Q4 and FY2026 results; trading window remains closed.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/779f2768-97e5-49f1-94c8-b425c01254c7.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/4baf02dc-c124-42f3-b09c-16005284cb95.pdf) |
| Feb 2026 | [Concall - Feb 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9db3f2e7-d649-4727-b22e-8ba4bd58cc16.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2025 from nse](https://archives.nseindia.com/annual_reports/AR_26991_SONAMLTD_2024_2025_A_17072025164353.pdf) |
| from nse | [Financial Year 2024 from nse](https://archives.nseindia.com/annual_reports/AR_25579_SONAMLTD_2023_2024_0309202417565.pdf) |
| from nse | [Financial Year 2023 from nse](https://archives.nseindia.com/annual_reports/AR_23016_SONAMCLOCK_2022_2023_28082023185430_08282023190019.zip) |
| from nse | [Financial Year 2022 from nse](https://archives.nseindia.com/annual_reports/AR_20064_SONAMCLOCK_2021_2022_17062022105803_06172022110002.zip) |
| from nse | [Financial Year 2021 from nse](https://archives.nseindia.com/annual_reports/SME_AR_18783_SONAMCLOCK_2020_2021_20082021125219_20082021130004.zip) |
| from nse | [Financial Year 2020 from nse](https://archives.nseindia.com/annual_reports/SME_AR_16472_SONAMCLOCK_2019_2020_17072020163349_17072020170002.zip) |
| from nse | [Financial Year 2019 from nse](https://archives.nseindia.com/annual_reports/SME_AR_15122_SONAMCLOCK_2018_2019_05082019113452_05082019120005.zip) |
| from nse | [Financial Year 2018 from nse](https://archives.nseindia.com/annual_reports/SME_AR_13242_SONAMCLOCK_2017_2018_28082018183831.zip) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:45:58.614Z.